Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Anixa Biosciences Inc (ANIX)

Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 101,442
  • Shares Outstanding, K 31,900
  • Annual Sales, $ 210 K
  • Annual Income, $ -9,810 K
  • 60-Month Beta 0.84
  • Price/Sales 466.35
  • Price/Cash Flow N/A
  • Price/Book 4.04
Trade ANIX with:

Options Overview Details

View History
  • Implied Volatility 152.42% ( +32.73%)
  • Historical Volatility 76.85%
  • IV Percentile 92%
  • IV Rank 32.44%
  • IV High 416.01% on 10/20/23
  • IV Low 25.86% on 11/14/23
  • Put/Call Vol Ratio 0.45
  • Today's Volume 268
  • Volume Avg (30-Day) 69
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 2,735
  • Open Int (30-Day) 3,461

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/24
See More
  • Average Estimate -0.11
  • Number of Estimates 1
  • High Estimate -0.11
  • Low Estimate -0.11
  • Prior Year -0.07
  • Growth Rate Est. (year over year) -57.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.94 +1.36%
on 04/25/24
3.48 -14.37%
on 04/01/24
-0.25 (-7.74%)
since 03/25/24
3-Month
2.94 +1.36%
on 04/25/24
4.70 -36.60%
on 02/01/24
-1.55 (-34.22%)
since 01/25/24
52-Week
2.75 +8.36%
on 11/22/23
5.13 -41.91%
on 01/18/24
-1.64 (-35.50%)
since 04/25/23

Most Recent Stories

More News
Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

ANIX : 2.98 (-6.29%)
Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

ANIX : 2.98 (-6.29%)
Anixa Biosciences Establishes Cancer Business Advisory Board

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

ANIX : 2.98 (-6.29%)
Jobs Numbers Roll out in Canada During Shortened Week

Monday Markets are closed for Labour Day Tuesday U.S. Economic Lookahead ...

ZS : 174.81 (-1.49%)
GTLB : 56.01 (-0.66%)
HQY : 79.04 (-0.20%)
CPRT : 55.22 (+0.53%)
PATH : 19.41 (-1.47%)
CNM : 56.75 (+1.05%)
TTS : 1.46 (-11.52%)
DOCU : 57.35 (+0.10%)
SAIC : 129.12 (+0.51%)
KR : 55.91 (-0.43%)
ANIX : 2.98 (-6.29%)
RENT : 11.54 (-4.39%)
Anixa Biosciences to Participate in September Investor Conferences

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

ANIX : 2.98 (-6.29%)
Anixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical Trial

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

ANIX : 2.98 (-6.29%)
Anixa Biosciences Announces Invited Presentation on Ovarian Cancer CAR-T Therapy at the 8th Annual CAR-TCR Summit

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

ANIX : 2.98 (-6.29%)
Anixa Biosciences Announces Opening of Enrollment for Keytruda® Arm in Ongoing Breast Cancer Vaccine Clinical Trial

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

MRK : 130.72 (+2.93%)
ANIX : 2.98 (-6.29%)
Anixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,...

ANIX : 2.98 (-6.29%)
Anixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical Trial

/PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that, in...

ANIX : 2.98 (-6.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States.

See More

Key Turning Points

3rd Resistance Point 3.60
2nd Resistance Point 3.46
1st Resistance Point 3.22
Last Price 2.98
1st Support Level 2.84
2nd Support Level 2.70
3rd Support Level 2.46

See More

52-Week High 5.13
Fibonacci 61.8% 4.22
Fibonacci 50% 3.94
Fibonacci 38.2% 3.66
Last Price 2.98
52-Week Low 2.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar